Theator Inc. announced that it will issue 1,200,516 series A-2 preferred shares at a price of $24.989255 per share for the gross proceeds of $30,000,000.46 on April 12, 2022. The company will issue securities pursuant to exemption provided under Regulation D. The series A-2 shares will be convertible into common shares at a fixed conversion price of $24.989255 per share.